UnitedHealth Group Incorporated (NYSE:UNH) Stock Holdings Lifted by Stokes Capital Advisors LLC

Stokes Capital Advisors LLC raised its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 6.0% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 20,455 shares of the healthcare conglomerate's stock after acquiring an additional 1,153 shares during the quarter. UnitedHealth Group makes up approximately 2.7% of Stokes Capital Advisors LLC's investment portfolio, making the stock its 9th largest position. Stokes Capital Advisors LLC's holdings in UnitedHealth Group were worth $10,713,000 at the end of the most recent reporting period.

A number of other large investors also recently bought and sold shares of the stock. Capital & Planning LLC raised its stake in shares of UnitedHealth Group by 19.2% during the 4th quarter. Capital & Planning LLC now owns 491 shares of the healthcare conglomerate's stock worth $248,000 after buying an additional 79 shares during the period. Brighton Jones LLC raised its stake in shares of UnitedHealth Group by 176.2% during the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock worth $22,384,000 after buying an additional 28,231 shares during the period. Union Bancaire Privee UBP SA purchased a new stake in shares of UnitedHealth Group during the fourth quarter worth approximately $27,233,000. Revolve Wealth Partners LLC increased its position in shares of UnitedHealth Group by 137.1% during the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock worth $2,033,000 after purchasing an additional 2,324 shares in the last quarter. Finally, Silver Oak Securities Incorporated increased its position in shares of UnitedHealth Group by 24.0% during the fourth quarter. Silver Oak Securities Incorporated now owns 2,878 shares of the healthcare conglomerate's stock worth $1,462,000 after purchasing an additional 557 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at UnitedHealth Group

In other news, Director Timothy Patrick Flynn purchased 1,533 shares of the business's stock in a transaction on Wednesday, May 14th. The shares were bought at an average price of $320.80 per share, with a total value of $491,786.40. Following the completion of the transaction, the director now directly owns 6,033 shares in the company, valued at approximately $1,935,386.40. This represents a 34.07% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director John H. Noseworthy purchased 300 shares of the business's stock in a transaction on Wednesday, May 14th. The shares were purchased at an average cost of $312.16 per share, for a total transaction of $93,648.00. Following the transaction, the director now owns 6,063 shares of the company's stock, valued at $1,892,626.08. This trade represents a 5.21% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last 90 days, insiders have acquired 109,408 shares of company stock valued at $31,607,768. Corporate insiders own 0.33% of the company's stock.

Analyst Ratings Changes

UNH has been the subject of several research reports. Mizuho dropped their price target on UnitedHealth Group from $515.00 to $350.00 and set an "outperform" rating for the company in a research report on Friday, May 16th. KeyCorp dropped their target price on UnitedHealth Group from $450.00 to $400.00 and set an "overweight" rating for the company in a report on Monday, June 2nd. Robert W. Baird dropped their target price on UnitedHealth Group from $510.00 to $356.00 and set an "outperform" rating for the company in a report on Wednesday, May 14th. Wolfe Research dropped their target price on UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating for the company in a report on Tuesday, May 20th. Finally, Truist Financial reiterated a "buy" rating and set a $360.00 price target (down from $580.00) on shares of UnitedHealth Group in a report on Monday, May 19th. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating and seventeen have assigned a buy rating to the company's stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $428.43.

UnitedHealth Group Stock Up 2.5%

UNH stock traded up $7.40 during mid-day trading on Friday, reaching $303.24. The company had a trading volume of 12,558,756 shares, compared to its average volume of 6,995,173. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The company has a market capitalization of $275.08 billion, a price-to-earnings ratio of 19.56, a price-to-earnings-growth ratio of 1.37 and a beta of 0.44. The firm has a fifty day simple moving average of $409.03 and a 200 day simple moving average of $484.21. UnitedHealth Group Incorporated has a fifty-two week low of $248.88 and a fifty-two week high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The company had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same period in the prior year, the business earned $6.91 EPS. Analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th will be given a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a dividend yield of 2.92%. The ex-dividend date is Monday, June 16th. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. UnitedHealth Group's dividend payout ratio (DPR) is 37.02%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.